PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities

Friday 31 May 2013, Amsterdam

PCR is used in a wide variety of molecular biology applications, including sequencing, genetic fingerprinting, cloning, disease research, diagnostics, drug discovery, disease biomarkers and forensics. Today, this technique continues to grow and some estimates suggest that by 2015 global markets for this technique will exceed $27 billion.

We have carried out a market study of the use of PCR in screening and diagnostics, involving the participation of 173 end-users and decision-makers in more than 50 countries. This study was carried out to investigate market developments, and to identify new insights and opportunities to developers and vendors in this field.

This study focused in particular on current and future techniques and applications, end-users’ plans for using PCR in screening and diagnostics over the next three years, as well as preferred products, purchasing and new developments. Other market areas included new and emerging applications, end-users’ principal PCR systems and their strengths and weaknesses, current and future budgets, budget breakdown, cost per sample, consumables, innovation, software and sample preparation.